DE69428763D1 - Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren - Google Patents

Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren

Info

Publication number
DE69428763D1
DE69428763D1 DE69428763T DE69428763T DE69428763D1 DE 69428763 D1 DE69428763 D1 DE 69428763D1 DE 69428763 T DE69428763 T DE 69428763T DE 69428763 T DE69428763 T DE 69428763T DE 69428763 D1 DE69428763 D1 DE 69428763D1
Authority
DE
Germany
Prior art keywords
specific
monoclonal antibodies
malignant tumors
gangliosides
active immunotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69428763T
Other languages
English (en)
Other versions
DE69428763T2 (de
Inventor
Ana Maria Vazquez Lopez
Angel Mauro Alfonso Fernandez
Rolando Perez Rodriguez
Amparo E Macias Abraham
Carlos Manuel Alvare Valcarcel
Ruiz Maria Eliana Lanio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Immunologia Molecular
Original Assignee
Centro de Immunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Immunologia Molecular filed Critical Centro de Immunologia Molecular
Publication of DE69428763D1 publication Critical patent/DE69428763D1/de
Application granted granted Critical
Publication of DE69428763T2 publication Critical patent/DE69428763T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69428763T 1993-12-09 1994-12-08 Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren Expired - Lifetime DE69428763T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1993114 1993-12-09

Publications (2)

Publication Number Publication Date
DE69428763D1 true DE69428763D1 (de) 2001-11-29
DE69428763T2 DE69428763T2 (de) 2002-08-01

Family

ID=5459390

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428763T Expired - Lifetime DE69428763T2 (de) 1993-12-09 1994-12-08 Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren

Country Status (6)

Country Link
US (1) US5817513A (de)
EP (1) EP0657471B1 (de)
JP (1) JP3003976B2 (de)
CA (1) CA2137638C (de)
DE (1) DE69428763T2 (de)
ES (1) ES2166770T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22702A1 (es) * 1997-10-21 2001-07-31 Centro Inmunologia Molecular Anticuerpos monoclonales anti - idiotipo, su uso en la inmunoterapia activa de tumores malignos, hibridoma que los produce y composiciones que los contienen
CU22585A1 (es) 1995-11-17 1999-11-03 Centro Inmunologia Molecular Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
CU22731A1 (es) * 1998-02-05 2002-02-28 Centro Inmunologia Molecular Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen
EA003318B1 (ru) * 1998-02-05 2003-04-24 Сентро Де Инмунология Молекулар ШТАММ ГИБРИДНЫХ КЛЕТОК МЫШИ, ПРОДУЦИРУЮЩИЙ МОНОКЛОНАЛЬНОЕ АНТИТЕЛО 14F7 ПРОТИВ ГАНГЛИОЗИДОВ NGcGM3, МОНОКЛОНАЛЬНОЕ АНТИТЕЛО 14F7, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И РЕАКТИВ, СОДЕРЖАЩИЕ УКАЗАННОЕ АНТИТЕЛО
US20030170249A1 (en) * 1999-02-19 2003-09-11 Hakomori Sen-Itiroh Vaccines directed to cancer-associated carbohydrate antigens
US6693176B1 (en) * 1999-07-23 2004-02-17 University Of Massachusetts Antitumor antibodies, proteins, and uses thereof
PE20020572A1 (es) * 2000-12-06 2002-07-31 Centro Inmunologia Molecular Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
GR1003883B (el) * 2001-05-09 2002-05-09 Εμβολιο παρεμποδισης μεταστασεων καρκινικων ογκων
WO2002094199A2 (en) * 2001-05-24 2002-11-28 Immucom Inc. METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
BR0211697A (pt) * 2001-08-03 2004-07-13 Biotron Ltd Marcador de câncer e usos deste na diagnose de câncer
AU2002351374A1 (en) * 2001-12-11 2003-06-23 Corixa Corporation Antibodies to treat cancer
US20040115204A1 (en) * 2002-12-11 2004-06-17 Fanger Gary R. Antibodies to treat cancer
EP2255787A4 (de) * 2008-02-22 2014-08-27 Katayama Chemical Ind Co Ltd Synthetische glycolipidhaltige liposomen
WO2010018846A1 (ja) * 2008-08-13 2010-02-18 協和発酵キリン株式会社 ガングリオシドgm2に特異的に結合する抗体組成物を含む医薬
WO2015179779A1 (en) * 2014-05-22 2015-11-26 Children's Hospital Medical Center Genomic instability markers in fanconi anemia
US11835502B2 (en) * 2017-09-27 2023-12-05 Rosetta Exosome Analysis method for extracellular vesicles, using size exclusion chromatography, and use for same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216406B (it) * 1986-12-12 1990-02-28 Enzo Alessandro Bet Cesoia a lame di taglioconscorrimento relativo.
PT89107A (pt) * 1987-11-30 1989-11-30 Idec Pharma Corp Metodo e meios para a seleccao de anticorpos anti-idiotipos e seu uso para o diagnostico, monitorizacao, tratamento e/ou prevencao de doencas cancerosas, da autoimunidade ou infecciosas
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5208146A (en) * 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies

Also Published As

Publication number Publication date
CA2137638A1 (en) 1995-06-10
CA2137638C (en) 1999-07-20
JP3003976B2 (ja) 2000-01-31
EP0657471A1 (de) 1995-06-14
JPH08163984A (ja) 1996-06-25
EP0657471B1 (de) 2001-10-24
DE69428763T2 (de) 2002-08-01
US5817513A (en) 1998-10-06
ES2166770T3 (es) 2002-05-01

Similar Documents

Publication Publication Date Title
DE69428763D1 (de) Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren
DE59104033D1 (de) Intumeszenzträger und deren Verwendung.
DE69224496D1 (de) Humaner monoklonaler Antikörper, spezifisch gegen ein Oberflächenantigen der Krebszell-Membran
DE59813875D1 (de) Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
AU7566991A (en) Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders
DE69531187D1 (de) Monoklonaler Antikörper gegen das Alpha-V-Integrin
AU5414996A (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
DE68918497D1 (de) Monoklonale Mäuseantikörper gegen HIV-IP24 und ihre Verwendung in Diagnostika.
IT1271461B (it) Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso.
DE69927268D1 (de) Spezifische antikörper enthaltende bindungsproteine die das nekrotische tumorzentrum binden und deren verwendung
DE59300501D1 (de) Verbesserte Intumeszenzträger und deren Verwendung.
DK0972782T3 (da) Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
NZ228837A (en) Tumour associated antigen and the monoclonal antibody reactive with it useful in diagnosing and treating cancer
AU9053991A (en) Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization
DK283588D0 (da) Monoklonalt antistof mod ovariecancerceller
DE58904019D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
SI1027375T1 (sl) Anti-idiotipska monoklonska protitelesa, njihova uporaba v aktivni imunoterapiji malignih tumorjev in sestavki, ki jih vsebujejo
DE3850325D1 (de) Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens.
DE69126302D1 (de) Monoklonaler antikörper gegen herzglykosid und dessen verwendung
AU2003204088A1 (en) Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
ITMI912195A0 (it) Dispositivo di chiusura per termos caraffe e simili
IL94304A0 (en) Novel tumor-associated antigen,antibodies,compositions and uses therefor
IT8321226V0 (it) Struttura di cerniera per borse, valigie e simili.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition